REGEN BIOLOGICS INC — Form D
REGEN BIOLOGICS INC of HACKENSACK, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2009-01-30. The offering totals $7.1M, of which $7.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-01-30
- Form: D
- Accession: 0000883697-09-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $7.1M
- Amount sold: $7.1M
- Investors: 31
- Date of first sale: 2009-01-16
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-88369-7P
Issuer
- Name: REGEN BIOLOGICS INC
- CIK: 0000883697
- Entity type: Corporation
- Jurisdiction: DE
- Address: 411 HACKENSACK AVENUE, HACKENSACK, NJ, 07601
- Phone: 2016515140
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| William G Rodkey | Executive Officer | Hackensack, NJ |
| Jeffrey Chandler | Executive Officer | Las Vegas, NV |
| Abhi Acharya | Director | Sandy Springs, GA |
| Robert G McNeil | Director | La Jolla, CA |
| William R Timken | Director | San Francisco, CA |
| J. Richard Steadman | Director | Hackensack, NJ |
| Alan W Baldwin | Director | Hackensack, NJ |
| Gerald E Bisbee, Jr. | Director | Hackensack, NJ |
| Gerald E Bisbee, Jr. | Executive Officer | Hackensack, NJ |
| William Rodkey | Executive Officer | Hackensack, NJ |
| Brion D Umidi | Executive Officer | Hackensack, NJ |
| James Flounlacker | Executive Officer | Hackensack, NJ |
| John Dichiara | Executive Officer | Hackensack, NJ |
Other filings by this issuer (1)
More